Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

football

- PMLiVE

Eisai pulls epilepsy drug Fycompa in Germany

Based on unfavourable assessment by pricing body

Kantar Media and Pointlogic unveil comms planning platform

Will determine most appropriate channel for reaching target audiences

- PMLiVE

Novartis launches European advanced breast cancer campaign

Campaign launches with audio/visual installation

- PMLiVE

GSK/ Valeant’s Trobalt set for EU restrictions

Eye concerns prompt CHMP to recommend last-line use for the epilepsy drug

UCB and IBM to harness big data for personalised epilepsy care

Joint project could pave the way for therapy area use of IBM's Watson

- PMLiVE

Steve Arnold joins UCB from Gilead

Appointed managing director for the British and Irish Isles

- PMLiVE

Sanofi invests €20m in Morocco

Will also collaborate with government on diabetes, mental health, epilepsy and pharma training

- PMLiVE

Sanofi supports Clexane with Spanish VTE apps

The free iPhone, iPad and Android apps are for healthcare professionals

- PMLiVE

From marketing to medical: Pharma’s informational source shift

The changing role of medical information in HCP communications pathways

- PMLiVE

Partial privatisation shakes up pharma market in Spain

Pharma struggling with unpaid drug bills, price cuts and cost-containment measures amid upheaval of healthcare system

- PMLiVE

Communicating clearly: using PowerPoint properly

How to design and use data slides that really add to your presentation.

- PMLiVE

UCB CEO: Patient info more important than transparency

Roch Doliveux says misinformation is the “worst thing that can happen in healthcare”

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links